OVERVIEW
The global market for immunoassay is projected to reach USD 27.9 billion by 2024, growing at 5.9% CAGR during the forecast period. The market’s growth is primarily driven by the increasing prevalence of chronic and infectious diseases and technological advances in the instruments of immunoassays.
TABLE OF CONTENT
1 Global Immunoassay Market
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope
2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions
3 Global Immunoassay Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography
4 Global Immunoassay Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis
5 Global Immunoassay Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies
6 Global Immunoassay Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes
7 Global Immunoassay Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)
8 Global Immunoassay Market – By Product & Service (Market Size – & million/billion)
8.1 Reagents & Kits
8.2 Analyzers
8.3 Software & Services
9 Global Immunoassay Market – By Platform
9.1 Chemiluminescence Immunoassays (CLIAs)
9.2 Fluorescence Immunoassays (FIAs)
9.3 Colorimetric Immunoassays (CIs)
9.4 Radioimmunoassays (RIAs)
9.5 Other
10 Global Immunoassay Market – By Technology
10.1 ELISA
10.2 Rapid Tests
10.3 Western Blotting
10.4 ELISPOT
10.5 Immuno-PCR
10.6 Other
11 Global Immunoassay Market – By Application
11.1 Infectious Diseases
11.2 Endocrinology
11.3 Oncology
11.4 Bone & Mineral Disorders
11.5 Cardiology
11.6 Other
12 Global Immunoassay Market – By End-User
12.1 Hospitals
12.2 Clinical Laboratories
12.3 Blood Banks
12.4 Research & Academic Laboratories
12.5 Other
13 Global Immunoassay Market – By Geography (Market Size – & million/billion)
13.1 Introduction
13.2 North America
13.2.1 US
13.2.2 Canada
13.2.3 Mexico
13.3 Europe
13.3.1 U.K
13.3.2 Germany
13.3.3 Italy
13.3.4 France
13.3.5 Spain
13.3.6 Rest of Europe
13.4 Asia-Pacific
13.4.1 China
13.4.2 Japan
13.4.3 India
13.4.4 South Korea
13.4.5 Rest of APAC
13.5 Rest of the World
13.5.1 South America
13.5.2 Middle East
13.5.3 Africa
14 Global Immunoassay Market – Entropy
14.1 New product launches
14.2 M&A’s, collaborations, JVs and partnerships
15 Global Immunoassay Market Company Profile (Key Players)
15.1 Market Share, Company Revenue, Products, M&A, Developments
15.2 Roche
15.3 Abbott Laboratories
15.4 Siemens
15.5 Biomérieux
15.6 Danaher
15.7 Qiagen
15.8 Thermo Fisher Scientific
15.9 Sysmex
15.10 Ortho Clinical Diagnostics
15.11 Diasorin
15.12 Company 11 & more
16 Global Immunoassay Market – Appendix
16.1 Sources
16.2 Abbreviations